EE Impact

El’Pharm

Ukraine · Pharma & Healthcare

LeaveRussia detail: Continue Operations

Still operating in Russia
Status last verified 03/08/2026Source checked 27/08/2024Company website ↗LeaveRussia profile ↗

Decision trail

Decision date 23/08/2024 · Reference ↗

El'Pharm was selling the Russian drug Cortexin, which is manufactured by Geropharm in the Moscow region, and medicines produced by Western companies specifically for the Russian market: "Atarax by the Belgian company UCB Pharma and Vobenzyme by the German company Mucos Pharma.

Status history since 2022

  1. 03/08/2026 operating · Imported from KSE LeaveRussia

Exposure profile

Full exposure profile is a Professional feature

Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.

Upgrade to Professional
Statuses, logos and narrative notes are compiled from public reporting and the KSE LeaveRussia project. Found an error? See our corrections policy.